- Home
- OCS vs THQ Comparison
OCS vs THQ Comparison
Compare OCS & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCS
- THQ
- Stock Information
- Founded
- OCS 2003
- THQ 2014
- Country
- OCS Switzerland
- THQ United States
- Employees
- OCS N/A
- THQ N/A
- Industry
- OCS Biotechnology: Pharmaceutical Preparations
- THQ Finance Companies
- Sector
- OCS Health Care
- THQ Finance
- Exchange
- OCS Nasdaq
- THQ Nasdaq
- Market Cap
- OCS 689.8M
- THQ 782.9M
- IPO Year
- OCS N/A
- THQ N/A
- Fundamental
- Price
- OCS $19.45
- THQ $18.30
- Analyst Decision
- OCS Strong Buy
- THQ
- Analyst Count
- OCS 4
- THQ 0
- Target Price
- OCS $31.50
- THQ N/A
- AVG Volume (30 Days)
- OCS 29.0K
- THQ 158.9K
- Earning Date
- OCS 05-08-2025
- THQ 01-01-0001
- Dividend Yield
- OCS N/A
- THQ 7.53%
- EPS Growth
- OCS N/A
- THQ N/A
- EPS
- OCS N/A
- THQ N/A
- Revenue
- OCS $847,333.00
- THQ N/A
- Revenue This Year
- OCS $53.79
- THQ N/A
- Revenue Next Year
- OCS $1,860.95
- THQ N/A
- P/E Ratio
- OCS N/A
- THQ N/A
- Revenue Growth
- OCS N/A
- THQ N/A
- 52 Week Low
- OCS $10.79
- THQ $15.29
- 52 Week High
- OCS $23.08
- THQ $20.38
- Technical
- Relative Strength Index (RSI)
- OCS 58.76
- THQ 47.57
- Support Level
- OCS $17.33
- THQ $17.82
- Resistance Level
- OCS $20.45
- THQ $18.73
- Average True Range (ATR)
- OCS 0.80
- THQ 0.36
- MACD
- OCS 0.19
- THQ 0.03
- Stochastic Oscillator
- OCS 68.75
- THQ 53.12
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
About THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest
Tekla Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies in the healthcare industry (including equity securities, debt securities, and pooled investment vehicles). The fund invests in securities of public and private companies.